Health Condition 1: F324- Major depressive disorder, singleepisode, in partial remission
Conditions
Interventions
Intervention1: tPEMF: Patients in treatment as usual + tPEMF group will be administered tPEMF additionally. We will use a table top apparatus DIAMAG (ALMAG-03) that generate low-frequency, low-intens
only a signal filled with zeroes. As the stimulator does not produce sound, heat, nor skin sensations, thus it becomes impossible for participants and the research team to distinguish between the acti
Sponsors
Dr Shilpa Mandal
Eligibility
Inclusion criteria
Inclusion criteria: Patients with Depressive disorder without psychotic features currently experiencing an depressive symptoms and in partial remission with 1st line treatment, aged between 18-60 years and consenting for the study will be enrolled. Comorbid anxiety symptoms will be permitted.
Exclusion criteria
Exclusion criteria: 1. Those diagnosed with Neurodevelopmental disorders, Schizophrenia/ psychotic disorders, OCD, Dissociative disorders, Eating disorders, Alcohol and Substance use disorders. 2. Neurological conditions like Movement disorders, Multiple sclerosis, Epilepsy, Cerebrovascular diseases and CNS infections. 3. Those having uncontrolled Diabetes, Hypertension or acute or chronic inflammatory conditions. 4. Those with history of endocrine diseases involving disorders of thyroid gland, parathyroid gland and adrenal gland. 5. Pregnant or lactating patients. 6. Those who have received any other form of neurostimulation in last 06 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the impact of adjuvant tPEMF on depressive symptomsTimepoint: At the end of 09 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Association between onset of depressive episode & improvement in depressive symptoms after adjuvant tPEMFTimepoint: At the end of 09 weeks | — |
Countries
India
Contacts
Public ContactShilpa Mandal
Armed Forces Medical College, Pune
Outcome results
None listed